Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Crown Laboratories in the transaction. Crown Laboratories, Inc. (“Crown”), a leading, fully integrated global skincare company, announced its agreement with Eclipse MedCorp LLC,...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented NexPhase Capital in the transaction. NexPhase Capital, LP (“NexPhase”), an operationally-focused private equity firm, executed its investment into Aztec Software (“Aztec”), an educational...
You must be a Standard 1 Year member to access this content.
